Gotu Kola 用于 年龄相关认知衰退
D 研究 目前仅存在初步研究(实验室研究、病例报告)。A traditional Ayurvedic brain tonic with emerging evidence for neuroprotective effects. Triterpene saponins promote nerve growth and dendritic arborization, but clinical evidence remains limited.
结论
A traditional Ayurvedic brain tonic with emerging evidence for neuroprotective effects. Triterpene saponins promote nerve growth and dendritic arborization, but clinical evidence remains limited.
Key Study Findings
研究人群: In vivo animal models of AD
研究人群: 18-month-old male and female C57BL6/J mice
研究人群: 3D intestinal model and neuronal/astrocytic co-culture
研究人群: Aged (18-month) C57BL6/J mice
研究人群: Patients with diabetes and Alzheimer's disease (review)
研究人群: In silico AD drug discovery (820 metabolites screened)
Key Statistics
4
研究数量
200
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 500-1,000 mg/day standardized extract
- cognitivesupport:
- 750 mg/day
上限: Not established; hepatotoxicity reported rarely at very high doses
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| 1000 mg/kg/day | -- | Positive | -- |
| None | -- | Positive | -- |
| 1000 mg/kg/day | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| 1 μg/mL | -- | Positive | -- |
最佳服用时间: With meals
Safety & Side Effects
已报告的副作用
- ⚠ Skin irritation (topical)
- ⚠ Headache
- ⚠ Gastrointestinal discomfort
- ⚠ Drowsiness
- ⚠ Rare: liver toxicity at very high doses
已知相互作用
- ● Hepatotoxic drugs (additive liver stress)
- ● Sedative medications (additive CNS depression)
- ● Cholesterol-lowering drugs (theoretical interaction)
可耐受最高摄入量: Not established; hepatotoxicity reported rarely at very high doses
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Gotu Kola help with 年龄相关认知衰退?
How much Gotu Kola should I take for 年龄相关认知衰退?
Are there side effects of Gotu Kola?
How strong is the evidence for Gotu Kola and 年龄相关认知衰退?
Related Evidence
References
- [1] Maryam N ALNasser et al.. Brain Sci. 2025. Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer's Treatment: Systematic Review. doi:10.3390/brainsci15020215 PubMed
- [2] Sandesh Kumar Pattanaik et al.. J Ethnopharmacol. 2025. Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments. doi:10.1016/j.jep.2025.120092 PubMed
- [3] Mohibullah Shah et al.. PLoS One. 2025. Computer-aided discovery of dual-target compounds for Alzheimer's from ayurvedic medicinal plants. doi:10.1371/journal.pone.0325441 PubMed
- [4] Rebecca Galla et al.. Foods. 2025. In Vitro Neuroprotective Effects of a Mixed Extract of Bilberry, Centella asiatica, Hericium erinaceus, and Palmitoylethanolamide. doi:10.3390/foods14152678 PubMed
- [5] Miski Aghnia Khairinisa et al.. Comput Biol Med. 2025. Bioactive potential of Centella asiatica leaf extract in acetylcholinesterase (AChE) inhibition: Insights from multiple ligand mapping. doi:10.1016/j.compbiomed.2025.110970 PubMed
- [6] Laura Dovek et al.. bioRxiv. 2025. Centella asiatica improves sleep quality and quantity in aged mice. doi:10.1101/2025.02.01.636070 PubMed
- [7] Laura Dovek et al.. Sleep Adv. 2025. Centella asiatica improves sleep quality and quantity in aged mice. doi:10.1093/sleepadvances/zpaf060 PubMed
- [8] Nora E Gray et al.. Front Aging. 2024. Amelioration of age-related cognitive decline and anxiety in mice by Centella asiatica extract varies by sex, dose and mode of … doi:10.3389/fragi.2024.1357922 PubMed
- [9] Zeba Firdaus et al.. J Ethnopharmacol. 2024. Centella asiatica improves memory and executive function in middle-aged rats by controlling oxidative stress and cholinergic transmission. doi:10.1016/j.jep.2024.117888 PubMed
- [10] Shuge Gui et al.. Food Sci Nutr. 2024. A mixture of extracts from natural ingredients reduces the neurotoxic polarization of microglia via modulating NF-κB/NF-E2-related factor 2 activation. doi:10.1002/fsn3.4045 PubMed
- [11] Takaya Suganuma et al.. J Alzheimers Dis. 2024. Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden. doi:10.3233/JAD-240033 PubMed
- [12] Donald G Matthews et al.. J Alzheimers Dis Rep. 2024. Centella asiatica improves cognitive function and alters the hippocampal metabolome of aged Tg2576 and wild-type mice. doi:10.1177/25424823241296740 PubMed
- [13] Nora E Gray et al.. bioRxiv. 2024. Amelioration of age-related cognitive decline and anxiety in mice by Centella asiatica extract varies by sex, dose and mode of … doi:10.1101/2024.01.23.576700 PubMed
- [14] Peeraporn Varinthra et al.. Tzu Chi Med J. 2023. Anti-inflammatory and memory-enhancing properties of Chinese herbal extracts: The possible application in Alzheimer's disease. doi:10.4103/tcmj.tcmj_139_22 PubMed
- [15] Honoka Fujimori et al.. J Pharmacol Sci. 2022. The protective effect of Centella asiatica and its constituent, araliadiol on neuronal cell damage and cognitive impairment. doi:10.1016/j.jphs.2021.11.001 PubMed
- [16] Julie Gregory et al.. Biomolecules. 2021. Neuroprotective Herbs for the Management of Alzheimer's Disease. doi:10.3390/biom11040543 PubMed
- [17] Jonathan A Zweig et al.. Neurobiol Aging. 2021. Loss of NRF2 accelerates cognitive decline, exacerbates mitochondrial dysfunction, and is required for the cognitive enhancing effects of Centella asiatica … doi:10.1016/j.neurobiolaging.2020.11.019 PubMed
- [18] Kirsten M Wright et al.. Front Nutr. 2021. Developing a Rational, Optimized Product of Centella asiatica for Examination in Clinical Trials: Real World Challenges. doi:10.3389/fnut.2021.799137 PubMed
- [19] Donald G Matthews et al.. Nutrients. 2020. Caffeoylquinic Acids in Centella asiatica Reverse Cognitive Deficits in Male 5XFAD Alzheimer's Disease Model Mice. doi:10.3390/nu12113488 PubMed
- [20] Kirsten M Wright et al.. Drug Metab Dispos. 2020. Centella asiatica Water Extract Shows Low Potential for Cytochrome P450-Mediated Drug Interactions. doi:10.1124/dmd.120.090860 PubMed
- [21] Jerome Sarris et al.. CNS Drugs. 2013. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. doi:10.1007/s40263-013-0059-9 PubMed
- [22] Pulok K Mukherjee et al.. Phytother Res. 2007. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. doi:10.1002/ptr.2224 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。